Disclosure Of Intangible Assets [Text Block]

Xbrane Biopharma - Filing #702448

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
49 672 SEK
4 083 SEK
Research and development expense
160 619 SEK
197 284 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.